StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)
StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research note published on Friday. The firm issued a sell rating on the medical technology company’s stock. Several other equities analysts have also weighed in on the company. Maxim Group lowered BIOLASE from a strong-buy rating to a hold rating in a […]
More Stories
Gold Prices Surge to Highest Level in Over 3 Months
By Naveen Athrappully Gold prices are trading at their highest level in more than three months on Monday, amid continued...
Treasury, IRS Propose Rules on Trump Account Investments
By Naveen Athrappully The Department of the Treasury and the IRS have issued proposed regulations clarifying which investments may be...
Iryna Zarutska’s Family Sues City of Charlotte Over Fatal Rail Stabbing, Blaming Security Failures
By Owen Evans The family of 23-year-old Ukrainian refugee Iryna Zarutska, who was stabbed to death in North Carolina, has...
IndyCar Race Caps Summer Events for America’s 250th Birthday
By Travis Gillmore WASHINGTON—More than 100,000 spectators lined the streets to witness history as drivers raced by national monuments on...
Zelenskyy Rejects Calls for Wartime Elections in Ukraine
By Tom Gantert Ukrainian President Volodymyr Zelenskyy said holding elections during the war with Russia would “destroy the country,” in...
DOJ Says Diplomat Discipline Board Can’t Overrule Secretary of State
By Matthew Vadum A Department of Justice (DOJ) body held that an independent board that reviews disciplinary actions against U.S....